245 New York — New York, New York

245 New York is a clinical research site located in New York, New York, United States 10007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

245 New York has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Hepatitis D Infection.

Sponsors: Mirum Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 245 New York?

245 New York has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 245 New York conducted?

245 New York has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Hepatitis D Infection.

Is 245 New York accredited by Crixeo Health?

245 New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 245 New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.